These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15369136)

  • 41. Human pulmonary natural killer (NK) cells exhibit limited lymphokine-activated killer (LAK) activity.
    Yarbrough WC; Weissler JC
    Am J Respir Cell Mol Biol; 1989 Oct; 1(4):305-11. PubMed ID: 2483121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice.
    Harada H; Suzu S; Ito T; Okada S
    Eur J Immunol; 2005 Dec; 35(12):3599-609. PubMed ID: 16304638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Transfection Efficiency of Ad5F11p-GFP on CIK and NK-92 Cells and Its Influence on Biological Characteristics].
    Xu ZM; Lu Y; Zhao LJ; Liu J; Hu XW; Wu CT; Duan HF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):873-7. PubMed ID: 27342525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of natural killer cytotoxicity in vitro by clinical grade serine protease inhibitors.
    Yamamoto M; Saigo K; Koshiba M; Kitamura N; Horie O; Ryo R; Kumagai S
    Haematologia (Budap); 2002; 32(2):103-11. PubMed ID: 12412729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of potent antitumour natural-killer cells from peripheral blood of patients with advanced prostate cancer.
    Oikawa T; Kawai K; Ishiwata I; Ohno T; Akaza H
    BJU Int; 2003 Dec; 92(9):1009-15. PubMed ID: 14632866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracellular calcium changes associated with in vitro lymphokine-activated killer and natural killer cell cytotoxicity.
    Burkey BB; Omann GM; Wolf GT
    Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1281-6. PubMed ID: 1747234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals.
    Ahmad A; Menezes J
    AIDS; 1996 Feb; 10(2):143-9. PubMed ID: 8838701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural killer and lymphokine-activated killer cell-mediated cytotoxicity in patients with oral cancer.
    Gangal SG; Tatake RJ; Krishnan N; Mukhopadhyaya R; Naik SL; Fakih AR; Rao RS
    Semin Surg Oncol; 1989; 5(5):347-50. PubMed ID: 2814145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay.
    Wierda WG; Mehr DS; Kim YB
    J Immunol Methods; 1989 Aug; 122(1):15-24. PubMed ID: 2760476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells.
    Shen RN; Lu L; Young P; Shidnia H; Hornback NB; Broxmeyer HE
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):821-6. PubMed ID: 8040029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of tumor-dendritic cell fusion vaccines on the cytotoxicity of CIK/NK cells from cord blood].
    Li Y; Huang SL; Wu YF; Wei J; Meng Y; Zhou DH; Bao R
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):269-72. PubMed ID: 15949286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG; Zeuthen J; Claësson MH
    Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM; Zhu HG; Anderer FA
    Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.
    Silla LM; Pincus SM; Locker JD; Glover J; Elder EM; Donnenberg AD; Nardi NB; Bryant J; Ball ED; Whiteside TL
    Br J Haematol; 1996 May; 93(2):375-85. PubMed ID: 8639431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A luminescent assay for natural cytotoxicity using K562 cells transfected with the plasmid producing alkaline phosphatase].
    Kasatori N
    Rinsho Byori; 2000 Feb; 48(2):178-83. PubMed ID: 10804823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology.
    Roden MM; Lee KH; Panelli MC; Marincola FM
    J Immunol Methods; 1999 Jun; 226(1-2):29-41. PubMed ID: 10410969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin.
    Shau H; Kim A; Golub SH
    J Leukoc Biol; 1992 Apr; 51(4):343-9. PubMed ID: 1564398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.